🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. early enteral nutrition

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Pancreatitis

    approved small molecule completed

    1 trial

  2. fecal microbiota transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    approved small molecule active

    1 trial

  3. film dressing by adhesive

    Chinese University of Hong Kong

    Chronic Peritoneal Dialysis

    approved other terminated

    1 trial

  4. first-line scheme+compound kushen injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Colorectal Carcinoma

    approved small molecule active

    1 trial

  5. gabapentin + tramadol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pain

    approved small molecule active

    1 trial

  6. handwashing

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Communicable Diseases

    approved other completed

    1 trial

  7. hydroxyethl starch

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cesarean Section

    approved small molecule completed

    1 trial

  8. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial

  9. intravenous sufentanil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule completed

    1 trial

  10. lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group

    Chinese University of Hong Kong

    Shock, Septic

    approved other completed

    1 trial

  11. lamivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Compensated Chronic Hepatitis B

    approved small molecule completed

    1 trial

  12. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  13. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  14. mesenchymal stromal cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    MSC

    approved mab active

    1 trial

  15. midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mechanical Ventilation

    approved small molecule active

    1 trial

  16. mirabegron

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  17. nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST-segment Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  18. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  19. phacoemulsification

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Astigmatism

    approved other active

    1 trial

  20. preoperative 0.5% ropivacaine hydrochloride preoperative

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule completed

    1 trial

  21. propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Sleep Quality

    approved small molecule completed

    1 trial

  22. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Birth

    approved small molecule completed

    1 trial

  23. recombinant human thrombopoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombocytopenia

    approved small molecule completed

    1 trial

  24. sIPV+DTaP+HepA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources